why choose us

First received: March 21, 2023

Clinical Trial: A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Fuchs Endothelial Corneal Dystrophy

Study Type: INTERVENTIONAL


Official Title: A Double-Masked, Randomized, Placebo-Controlled, Parallel-Group, 12-Week Administration With Two-Week Gradual Dose Taper Phase and 38-Week Follow-Up Phase, Phase 3 Study to Investigate the Safety and

Brief Summary: A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.

Read more